Science:Life Sciences
A broad range of serious diseases involve chronic inflammation, which causes both pain and progressive damage. Xalud Therapeutics is developing a locally-delivered, non-viral gene therapy that is designed to harness the ability of interleukin-10 to regulate the immune system and restore homeostasis. The company’s lead indication is in osteoarthritis We spoke to Diem Nguyen, CEO of Xalud, about the role inteleukin-10 plays in regulating multiple pathways in the immune system, Xalud’s gene therapy, and the indications the company is pursuing.
view more
More Episodes
Making A Social Contract That’s Enforceable
2020-03-12
2020-03-12
Fishing for New Drugs
2020-02-27
2020-02-27
Quantifying Neurodegeneration with Precision
2020-01-30
2020-01-30
Reversing Disease Signals
2020-01-16
2020-01-16
Turning Cold Tumors Hot
2020-01-09
2020-01-09
An Effort to Eradicate Preventable Blindness
2019-12-20
2019-12-20
Seeking Success Where Others Have Failed
2019-12-19
2019-12-19
Improving Health with Better Data
2019-12-05
2019-12-05
Get this podcast on your
phone, FREE
